Tag Archives | Cannabis Sativa

Ten Great Reasons to Kill America’s Ban on Growing Hemp

Aleks (CC)

Alternet’s Scott Thill writing at Wake Up World:

America’s industrial ban on hemp is “a poster child for dumb regulation,” argues lazy ass pothead! Wait, sorry, scratch that. Make that Senator Ron Wyden, D-Oregon, introducing an amendment last week to the densely contested 2012 Farm Bill, which is either a subsidies and sustainability savior or callous food austerity, depending on who you ask. But if you ask Wyden, “the best possible Farm Bill” is one that repeals a ban on industrial hemp the United States is already quite busy, and expensively, importing from the few feet it takes to cross the Canadian border.

“I will be urging my colleagues to support this amendment,” Wyden announced last week on the Senate floor, reminding the assembled elected that his plan won’t cost American taxpayers a dime. “I want [them] to know I will be back at this again until there are smarter regulations in place.”

“America needs to get real about hemp, and fast, even if the country continues to fight about ending cannabis prohibition,” National Organization for the Reform of Marijuana Laws (NORML) executive director Allen St.

Read the rest

Continue Reading

Will Big Pharma Take Over The American Market For Medical Marijuana?

MedMarjIf the hundreds of uses for cannabis doesn’t plead the case for its legalization, the money made from its medical industry just might do it. The Washington Independent reports:

The American Independent has previously reported on the growing corporatization of the incipient medical marijuana industry at a time when medical marijuana dispensaries scrabble to hold on to their businesses in the face of a multi-pronged federal crackdown. But there are signs afoot that it just may become ever more corporate if a Big Pharma push to get the U.S. Food and Drug Administration to recognize a cannabis-derived drug is successful.

Last week, British prescription drug manufacturer GW Pharmaceuticals announced a licensing agreement with drug giant Novartis, maker of Ritalin and Excedrin, to begin selling GW’s drug Sativex in markets across Asia, Africa, Oceania and the Middle East. The medication is already available in Britain, where it’s produced and marketed by Bayer, and in Canada and Spain.

Read the rest

Continue Reading